Abstract
Ocular features may occur in longstanding rheumatoid arthritis. Among them, scleritis represents the most frequent manifestation of ophthalmologic rheumatoid disease. There are three types of anterior scleritis: diffuse, nodular, and necrotizing with and without inflammation (scleromalacia perforans). Nodular scleritis is the second cause of anterior scleritis representing 20% of all types of scleritis. The conventional treatment of nodular scleritis consists in topical steroids and DMARDS. In severe cases, the therapy with immunosuppressive agents to avoid complications is necessary. We describe a 46-year-old woman presented right nodular scleritis with rheumatoid arthritis. She was treated initially with topical steroids and DMARDs but was unable to received systemic steroids due to left open angle glaucoma in the opposite eye. After an ocular exacerbation, we initiated adalimumab with complete resolution of nodular scleritis. This is the first report of adalimumab in the treatment of nodular scleritis. Adalimumab could be a good alternative in patients with severe nodular scleritis who fail to have conventional treatment with DMARDs and unable to receive systemic steroids.
This is a preview of subscription content, log in via an institution to check access.
References
Harper S, Foster C (1998) The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin 38:1–19
McGavin D, Williamson J, Forrester J, Foulds W, Buchanan W, Dick W et al (1976) Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophtalmol 60:192–226
Jabs D, Mudun A, Dunn J, Marsh M (2000) Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 130:469–476
Fuerst D, Tanzer D, Smith R (1998) Rheumatoid diseases. Int Ophthalmol Clin 38:47–80
Watson P, Hayreh S (1976) Scleritis and episcleritis. Br J Ophthalmol 60:163–191
Sen H, Sangare A, Hammel K, Levy-Clarke G, Nussenblatt R (2009) Infliximab for the treatment of active scleritis. Can J Ophtalmol 44:e9–e12
Ashok D, Ayliffe W, Kiely P (2005) Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy. Rheumatol 44:950–951
Ahn S, Oh J, Kim M, Wee W (2009) Treatment of refractory scleritis with infliximab. Jpn J Ophtalmol 53:286–287
Chauhan S, Kamal A, Thompson R, Estrach C, Moots R (2009) Rituximab for the treatment associated with rheumatoid arthritis. Br J Ophtalmol 93:984–985
Keystone E, Kavanaugh A, Sharp J, Tannenbaum H, Hua Y, Teoh L et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50:1400–1411
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Restrepo, J.P., Molina, M.P. Successful treatment of severe nodular scleritis with adalimumab. Clin Rheumatol 29, 559–561 (2010). https://doi.org/10.1007/s10067-009-1368-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-009-1368-8